Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Hospitalisation rates for youth living with perinatally acquired HIV in England.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
      HIV* ; HIV Infections*; Adolescent ; Adult ; Female ; Humans ; Male ; Young Adult ; CD4 Lymphocyte Count ; Hospitalization ; Retrospective Studies ; Child ; Black People ; Caribbean People ; African People
    • Abstract:
      Competing Interests: The authors have declared that no competing interests exist.
      Introduction: Complex challenges amongst ageing cohorts of adolescents and adults living with perinatally acquired HIV (PaHIV) may impact on hospitalisation. We report hospitalisation rates and explored predictive factors for hospitalisation in adolescents and adults (10-35 years) living with PaHIV in England.
      Method: Retrospective observational cohort study over a three-year period 2016-2019. Data collected included cause and duration of hospitalisation, HIV viral load and CD4 lymphocyte count. The primary outcome was overnight hospitalisation. Patients exited at study end/ transfer of care (TOC)/ loss to follow up (LTFU) or death. Maternity/hospital admissions at other centres were excluded. Admission rates per 100 person-years (95% CI) were calculated by age group. Negative binomial regression with generalized estimating equations was performed.
      Results: 255 patients contributed 689 person-years of follow up. 56% were female and 83% were of a Black, Black British, Caribbean or African ethnicity. At baseline, the median age was 19 years (IQR 16-22). 36 individuals experienced a total of 62 admissions which resulted in 558 overnight stays (median stay was 5 nights). One person died (lymphoma), six had TOC and one was LTFU by the end of the three-year study period. Crude incidence of admission for the whole cohort was 9.0 per 100 PY (6.9-11.6). The respective crude incidence rates were 1.5 PY (0.0-8.2) in those aged 10-14 years and 3.5 PY (1.5-7.0) in the 15-19-year-olds. In those aged 20-24 years it was 14.5 PY (10.1-20.2) and in those >25 years the crude incidence rate was 11.7 PY (6.9-18.5). Factors significantly associated with admission were a CD4 lymphocyte count <200 cells/uL, adjusted IRR 4.0 (1.8-8.8) and a history of a CDC-C diagnosis, adjusted IRR 2.9 (1.6-5.3). 89% admissions were HIV-related: 45% new/current CDC-C diagnoses, 76% due to infection.
      Conclusions: Hospitalisation rates were four-fold higher in adults (>20 years of age) compared to adolescents (10-19-year-olds). The continuing challenges experienced by PaHIV youth require enhanced multidisciplinary support throughout adulthood.
      (Copyright: © 2024 Johnson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      BMC Public Health. 2020 Aug 3;20(1):1195. (PMID: 32746881)
      J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):503-10. (PMID: 22487588)
      PLoS Med. 2018 Mar 1;15(3):e1002514. (PMID: 29494593)
      AIDS. 2008 Jul 11;22(11):1345-54. (PMID: 18580614)
      Lancet HIV. 2015 Oct;2(10):e438-44. (PMID: 26423651)
      HIV Med. 2013 Nov;14(10):605-13. (PMID: 23773723)
      J Int AIDS Soc. 2017 May 16;20(Suppl 3):21577. (PMID: 28530042)
      Medicine (Baltimore). 2015 Dec;94(50):e2269. (PMID: 26683950)
      Medicine (Baltimore). 2017 May;96(18):e6812. (PMID: 28471983)
      Pediatrics. 2009 Dec;124(6):e1134-41. (PMID: 19933731)
      PLoS Med. 2010 Feb 02;7(2):e1000178. (PMID: 20126383)
      Lancet Infect Dis. 2014 Jul;14(7):627-39. (PMID: 24406145)
      AIDS Care. 2017 Jul;29(7):885-889. (PMID: 27973920)
      J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):295-301. (PMID: 32678875)
      AIDS Behav. 2013 Jan;17(1):86-93. (PMID: 23142855)
      Pediatr Infect Dis J. 2014 May;33(5):488-94. (PMID: 24378943)
      BMC Infect Dis. 2021 Apr 29;21(1):395. (PMID: 33926373)
      AIDS. 2020 Feb 1;34(2):261-266. (PMID: 31651427)
      J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):368-75. (PMID: 22240460)
      Clin Infect Dis. 2017 Apr 15;64(8):1105-1112. (PMID: 28329212)
      HIV Med. 2021 Sep;22(8):631-640. (PMID: 33939876)
      Pediatr Infect Dis J. 2021 Apr 1;40(4):347-350. (PMID: 33264211)
      Lancet. 2013 Nov 9;382(9904):1555-63. (PMID: 24209829)
      Clin Infect Dis. 2018 Mar 4;66(suppl_2):S126-S131. (PMID: 29514239)
      AIDS. 2021 Feb 2;35(2):245-255. (PMID: 33170817)
    • Publication Date:
      Date Created: 20240319 Date Completed: 20240321 Latest Revision: 20240402
    • Publication Date:
      20250114
    • Accession Number:
      PMC10950242
    • Accession Number:
      10.1371/journal.pone.0295639
    • Accession Number:
      38502654